All terms in HP
| Label | Id | Description |
|---|---|---|
| Decreased circulating corticosterone level | HP_0032363 | [An abnormally reduced concentration of corticosterone in the blood.] |
| Increased circulating corticosterone level | HP_0032362 | [An abnormally elevated concentration of corticosterone in the blood.] |
| Decreased post-bronchodilator forced expiratory flow 25-75% | HP_0032361 | [A reduction compared to the predicted value of the forced expiratory flow over the middle one-half of the FVC; the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled. Here, the test is performed after the administration of a bronchodilating medication.] |
| Abnormal spirometry test | HP_0032340 | [An abnormal spirometry test result. In this test, the individual being tested exhales into a tube connected to a machine called a spirometer, which measures the volume of air expired against time. Patients are asked to take a maximal inspiration and then to forcefully expel air for as long and as quickly as possible.] |
| Decreased post-bronchodilator forced expiratory volume in one second | HP_0032358 | [An abnormal reduction in the amount of air a person can forcefully expel in one second, with the test being performed after the administration of a bronchodilating medication.] |
| Reduced forced expiratory volume in one second | HP_0032342 | |
| Decreased post-bronchodilator forced vital capacity | HP_0032357 | [An abnormal reduction in the amount of air a person can expel following maximal insipiration, with the test being performed after the administration of a bronchodilating medication.] |
| Reduced forced vital capacity | HP_0032341 | [An abnormal reduction in the amount of air a person can expel following maximal insipiration.] |
| Decreased pre-bronchodilator forced vital capacity | HP_0032356 | [An abnormal reduction in the amount of air a person can expel following maximal insipiration, with the test being performed before the administration of a bronchodilating medication.] |
| Decreased peak expiratory flow | HP_0032355 | [A reduction in the maximum expiratory flow per minute, which can be used to measure how fast a subject can exhale as well as to judge the strength of the expiratory muscles and the condition of the large airways.] |
| Leucinuria | HP_0032353 | [Increased level of leucine in urine.] |
| Methioninuria | HP_0032352 | [Increased level of methionine in urine.] |
| Phenylalaninuria | HP_0032351 | [Increased level of phenylalanine in urine.] |
| Sulfocysteinuria | HP_0032350 | [A increased concentration of sulfocysteine in the urine.] |
| mesothelial cell of visceral peritoneum | CL_1000457 | [A mesothelial cell that is part of the visceral peritoneum.] |
| mesothelial cell of peritoneum | CL_1000490 | [A mesothelial cell that is part of the peritoneum.] |
| mesothelial cell of parietal peritoneum | CL_1000456 | [A mesothelial cell that is part of the parietal peritoneum.] |
| Uniparental disomy | HP_0032382 | [Inheritance of both homologues of a chromosome pair from the same parent.] |
| Hydroa vacciniforme | HP_0032381 | [In response to the spring sun distinct inflamed reddened skin develops on the ears, nose, cheeks, fingers, backs of the hands, and the lower arms, on which blisters with serous or hemorrhagic content develop. These dry out with the formation of a blackish scab. After shedding of the scab, depressed, varioliform, often hypopigmented scars remain. In addition, hyper- and hypopigmentation are present together, resulting in a polymorphous skin presentation.] |
| positive regulation of immune effector process | GO_0002699 | [Any process that activates or increases the frequency, rate, or extent of an immune effector process.] |